A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy
Author:
Funder
Bristol-Myers Squibb
Indian Council of Medical Research
Umm Al-Qura University
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference71 articles.
1. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the national cancer institute's surveillance, epidemiology, and end results database;Morris;Cancer,2007
2. Metastatic and triple-negative breast cancer: challenges and treatment options;Al-Mahmood;Drug Deliv. Transl. Res.,2018
3. Photo-triggered destabilization of nanoscopic vehicles by dihydroindolizine for enhanced anticancer drug delivery in cervical carcinoma;Singh;Colloids Surf. B Biointerfaces,2018
4. Journey of anthraquinones as anticancer agents – a systematic review of recent literature;Malik;RSC Adv.,2021
5. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro;Mukhopadhyay;Am. J. Physiol. Heart Circ. Physiol.,2009
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Doxorubicin-sanguinarine nanoparticles: formulation and evaluation of breast cancer cell apoptosis and cell cycle;Drug Development and Industrial Pharmacy;2024-01-05
2. WITHDRAWN: Recent progress in functionalized and targeted polymersomes and chimeric polymeric nanotheranostic platforms for cancer therapy;Progress in Materials Science;2023-12
3. Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer;Frontiers in Bioengineering and Biotechnology;2023-11-17
4. Drug permeation enhancement, efficacy, and safety assessment of azelaic acid loaded SNEDDS hydrogel to overcome the treatment barriers of atopic dermatitis;Environmental Research;2023-11
5. Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics;Molecular Cancer;2023-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3